Dieter Köberle

1.0k total citations
23 papers, 781 citations indexed

About

Dieter Köberle is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Dieter Köberle has authored 23 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Dieter Köberle's work include Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Breast Cancer Treatment Studies (5 papers). Dieter Köberle is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Breast Cancer Treatment Studies (5 papers). Dieter Köberle collaborates with scholars based in Switzerland, Germany and Austria. Dieter Köberle's co-authors include Beat Thürlimann, Markus Borner, Lucien Perey, Aron Goldhirsch, Kaspar Rufibach, Michel Seymour, Nicola Fazio, Martin Wernli, Piercarlo Saletti and Lukas Werner Widmer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Dieter Köberle

23 papers receiving 763 citations

Peers

Countries citing papers authored by Dieter Köberle

Since Specialization

Citations

This map shows the geographic impact of Dieter Köberle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dieter Köberle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dieter Köberle more than expected).

Fields of papers citing papers by Dieter Köberle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dieter Köberle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dieter Köberle. The network helps show where Dieter Köberle may publish in the future.

Co-authorship network of co-authors of Dieter Köberle

This figure shows the co-authorship network connecting the top 25 collaborators of Dieter Köberle. A scholar is included among the top collaborators of Dieter Köberle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dieter Köberle. Dieter Köberle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer 2023 ·Gastric Cancer ·Florian Lordick, Salah‐Eddin Al‐Batran, Dirk Arnold, Markus Borner, Christiane J. Bruns, Wolfgang Eisterer, (unknown), Ines Gockel, Dieter Köberle, Sylvie Lorenzen, Markus Möhler, Ron Pritzkuleit, M. Stahl, Peter Thuss‐Patience, Ewald Wöll, Thomas Zander, Georg Maschmeyer	3
2	Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes 2017 ·PLoS ONE ·(unknown), Luca Quagliata, Mariacarla Andreozzi, Serenella Eppenberger‐Castori, Matthias S. Matter, Valeria Perrina, Rainer Grobholz, Wolfram Jochum, Daniel Horber, Peter Moosmann, Frank Serge Lehmann, Dieter Köberle, Charlotte K.Y. Ng, Salvatore Piscuoglio, Luigi Tornillo, Luigi Terracciano	15
3	Current Treatment of Isolated Locoregional Breast Cancer Recurrences 2015 ·Breast Care ·Wolfgang Harms, (unknown), (unknown), Martin Buess, Dieter Köberle, (unknown)	11
4	A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer 2014 ·European Journal of Cancer ·Lothar Bergmann, Luise Maute, Gerhard Heil, Jörn Rüssel, Eckhart Weidmann, Dieter Köberle, Stefan Fuxius, K. Weigang-Köhler, Walter E. Aulitzky, Bernhard Wörmann, G. Hartung, Berta Moritz, Lutz Edler, Iris Burkholder, M. E. Scheulen, Heike Richly	51
5	Perioperative Blood Transfusions Do Not Impact Overall and Disease-Free Survival After Curative Rectal Cancer Resection 2013 ·Annals of Surgery ·René Warschkow, Ulrich Güller, Dieter Köberle, Sascha Müller, Thomas Steffen, Martin Thurnheer, Bruno M. Schmied, Ignazio Tarantino	39
6	Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study 2012 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), Dieter Köberle, Stefan Schürch, (unknown), (unknown), Tanja K. Froehlich, Carlo R. Largiadèr, Markus Joerger	70
7	Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients 2012 ·British Journal of Cancer ·Ignazio Tarantino, René Warschkow, Mathias Worni, (unknown), Dieter Köberle, Bruno M. Schmied, Sascha Müller, Thomas Steffen, T. Cerny, Ulrich Güller	50
8	Oxaliplatin, Irinotecan and Capecitabine (OCX) for First-Line Treatment of Advanced/Metastatic Colorectal Cancer: A Phase I Trial (SAKK 41/03) 2010 ·Onkologie ·Roger von Moos, Arnaud Roth, Thomas Ruhstaller, (unknown), Catrina Uhlmann, Richard Cathomas, Dieter Köberle, Mathew Simcock, Doris Lanz, Răzvan Popescu	3
9	Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates 2010 ·Cancer Chemotherapy and Pharmacology ·Markus Joerger, Arnoud J. Templeton, Dieter Köberle, H. Engler, Walter F. Riesen, Beat Thürlimann	2
10	Heated (37°C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy? 2009 ·Supportive Care in Cancer ·Richard Cathomas, Dieter Köberle, Thomas Ruhstaller, (unknown), (unknown), Ulrich Mey, Roger von Moos	6
11	Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02) 2009 ·Annals of Oncology ·Thomas Ruhstaller, (unknown), Jan C. Schuller, A. Roth, Viviane Hess, Walter Mingrone, Roger von Moos, Markus Borner, Bernhard C. Pestalozzi, (unknown), Dieter Köberle, L. Terraciano, Armin Schnider, Stephan Bodis, Răzvan Popescu	60
12	Limited Predictive Value of FDG-PET for Response Assessment in the Preoperative Treatment of Esophageal Cancer: Results of a Prospective Multi-Center Trial (SAKK 75/02) 2009 ·Onkologie ·Bernd Klaeser, Egbert Nitzsche, Jan C. Schuller, Dieter Köberle, (unknown), (unknown), Thomas F. Hany, (unknown), Peter Brauchli, (unknown), Bernhard C. Pestalozzi, Clemens B. Caspar, Susanne Albrecht, Roger von Moos, Thomas Ruhstaller	42
13	Concordant colon tumors in monozygotic twins previously treated for prostate cancer 2008 ·Familial Cancer ·Arnoud J. Templeton, Giancarlo Marra, Emanuele Valtorta, Karl Heinimann, Hansjakob Müller, Dieter Köberle, Silke Gillessen	4
14	Combining chemotherapy and low-molecular-weight heparin for the treatment of advanced breast cancer: results on clinical response, transforming growth factor-beta 1 and fibrin monomer in a phase II study 2007 ·Blood Coagulation & Fibrinolysis ·(unknown), Beat Thürlimann, Dieter Köberle, Dagmar Hess, Wolfgang Korte	14
15	Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast Cancer 2007 ·Oncology ·Dagmar Hess, Dieter Köberle, Beat Thürlimann, Olivia Pagani, (unknown), (unknown), Christoph Rochlitz, Daniel Rauch, J. Schüller, Pierluigi Ballabeni, Karin Ribi	20
16	Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 2006 ·Annals of Oncology ·Lucien Perey, Robert Paridaens, Hanne Hawle, Khalil Zaman, Franco Nolè, (unknown), Maryse Fiche, D. Dietrich, Patrice Clément, Dieter Köberle, Aron Goldhirsch, Beat Thürlimann	103
17	Adjuvant endocrine therapy in postmenopausal breast cancer patients 2005 ·The Breast ·Dieter Köberle, Beat Thürlimann	3
18	Neuropeptide chronomics in clinically healthy young adults: circaoctohoran and circadian patterns 2004 ·Peptides ·(unknown), Dieter Köberle, Paul König, Alois Saria, Manfred Herold, Germaine Cornélissen, Franz Halberg	19
19	Anastrozole (‘Arimidex’) versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: Results of the double-blind cross-over SAKK trial 21/95 - a sub-study of the TARGET (Tamoxifen or ‘Arimidex’ Randomized Group Efficacy and Tolerability) trial 2004 ·Breast Cancer Research and Treatment ·Beat Thürlimann, Dagmar Hess, Dieter Köberle, (unknown), Pierluigi Ballabeni, Olivia Pagani, Lucien Perey, Stefan Aebi, Christoph Rochlitz, Aron Goldhirsch	51
20	Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer 2001 ·Expert Review of Anticancer Therapy ·Dieter Köberle, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact